INHIBIKASE THERAPEUTIC
1.2500
07-October-24 14:59:55
15 minutes delayed
Stocks
-0.0100
-0.79%
Today's range
1.2000 - 1.3100
ISIN
N/A
Source
NASDAQ
-
14 Aug 2024 15:25:26 By Nasdaq GlobeNewswire
-
Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
07 Aug 2024 07:00:08 By Nasdaq GlobeNewswire
-
17 Jun 2024 07:05:00 By Nasdaq GlobeNewswire
-
05 Jun 2024 07:05:00 By Nasdaq GlobeNewswire
-
20 May 2024 07:01:00 By Nasdaq GlobeNewswire
-
15 May 2024 19:00:00 By Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement
15 May 2024 07:45:00 By Nasdaq GlobeNewswire
-
09 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
18 Apr 2024 15:30:00 By Nasdaq GlobeNewswire
-
03 Apr 2024 07:05:00 By Nasdaq GlobeNewswire
-
27 Mar 2024 15:15:20 By Nasdaq GlobeNewswire
-
07 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro
28 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
07 Feb 2024 06:55:00 By Nasdaq GlobeNewswire
-
29 Jan 2024 08:05:00 By Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli
16 Jan 2024 15:05:00 By Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
19 Dec 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Granted Pre-NDA Meeting with the FDA for IkT-001Pro
04 Dec 2023 07:35:00 By Nasdaq GlobeNewswire
-
14 Nov 2023 15:30:06 By Nasdaq GlobeNewswire
-
07 Nov 2023 08:28:32 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >